266 related articles for article (PubMed ID: 26165848)
1. Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms.
Lopez FL; Ernest TB; Tuleu C; Gul MO
Expert Opin Drug Deliv; 2015; 12(11):1727-40. PubMed ID: 26165848
[TBL] [Abstract][Full Text] [Related]
2. A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms.
Zajicek A; Fossler MJ; Barrett JS; Worthington JH; Ternik R; Charkoftaki G; Lum S; Breitkreutz J; Baltezor M; Macheras P; Khan M; Agharkar S; MacLaren DD
AAPS J; 2013 Oct; 15(4):1072-81. PubMed ID: 23907486
[TBL] [Abstract][Full Text] [Related]
3. Advancements in the delivery of epigenetic drugs.
Cramer SA; Adjei IM; Labhasetwar V
Expert Opin Drug Deliv; 2015; 12(9):1501-12. PubMed ID: 25739728
[TBL] [Abstract][Full Text] [Related]
4. Development and approval of novel injectables: enhancing therapeutic innovations.
Yadav P; Singh Y; Chauhan D; Yadav PK; Kedar AS; Tiwari AK; Shah AA; Gayen JR; Chourasia MK
Expert Opin Drug Deliv; 2024 Apr; 21(4):639-662. PubMed ID: 38703363
[TBL] [Abstract][Full Text] [Related]
5. A Novel Method to Optimize Drug Delivery for Parenteral Products Involving New Therapies and Unmet Needs.
Khanolkar A; White S; Margerison E
Pharm Res; 2023 Oct; 40(10):2303-2315. PubMed ID: 37012534
[TBL] [Abstract][Full Text] [Related]
6. Pediatric Drug Development: Reviewing Challenges and Opportunities by Tracking Innovative Therapies.
Domingues C; Jarak I; Veiga F; Dourado M; Figueiras A
Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896191
[TBL] [Abstract][Full Text] [Related]
7. Advanced Formulation Approaches for Proteins.
Schlosser CS; Williams GR; Dziemidowicz K
Handb Exp Pharmacol; 2024; 284():69-91. PubMed ID: 37059912
[TBL] [Abstract][Full Text] [Related]
8. Calcium and phosphorus compatibility in parental nutrition solutions for neonates.
Eggert LD; Rusho WJ; MacKay MW; Chan GM
Am J Hosp Pharm; 1982 Jan; 39(1):49-53. PubMed ID: 6798868
[TBL] [Abstract][Full Text] [Related]
9. Compatibility of calcium chloride and calcium gluconate with sodium phosphate in a mixed TPN solution.
Henry RS; Jurgens RW; Sturgeon R; Athanikar N; Welco A; Van Leuven M
Am J Hosp Pharm; 1980 May; 37(5):673-4. PubMed ID: 6770681
[TBL] [Abstract][Full Text] [Related]
10. Compatibility and stability of additives in parenteral nutrition admixtures.
Allwood MC; Kearney MC
Nutrition; 1998 Sep; 14(9):697-706. PubMed ID: 9760591
[TBL] [Abstract][Full Text] [Related]
11. FDA safety alert: hazards of precipitation associated with parenteral nutrition.
McKinnon BT
Nutr Clin Pract; 1996 Apr; 11(2):59-65. PubMed ID: 8788339
[TBL] [Abstract][Full Text] [Related]
12. The solubility of calcium and phosphate in two specialty amino acid solutions.
MacKay MW; Fitzgerald KA; Jackson D
JPEN J Parenter Enteral Nutr; 1996; 20(1):63-6. PubMed ID: 8788265
[TBL] [Abstract][Full Text] [Related]
13. Fatal microvascular pulmonary emboli from precipitation of a total nutrient admixture solution.
Hill SE; Heldman LS; Goo ED; Whippo PE; Perkinson JC
JPEN J Parenter Enteral Nutr; 1996; 20(1):81-7. PubMed ID: 8788269
[TBL] [Abstract][Full Text] [Related]
14. Safety alert: hazards of precipitation associated with parenteral nutrition.
Lumpkin MM
Am J Hosp Pharm; 1994 Jun; 51(11):1427-8. PubMed ID: 7942876
[No Abstract] [Full Text] [Related]
15. Pediatric Oral Formulations: An Updated Review of Commercially Available Pediatric Oral Formulations Since 2007.
Strickley RG
J Pharm Sci; 2019 Apr; 108(4):1335-1365. PubMed ID: 30447227
[TBL] [Abstract][Full Text] [Related]
16. Drug Formulations: Standards and Novel Strategies for Drug Administration in Pediatrics.
Thabet Y; Klingmann V; Breitkreutz J
J Clin Pharmacol; 2018 Oct; 58 Suppl 10():S26-S35. PubMed ID: 30248193
[TBL] [Abstract][Full Text] [Related]
17. Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspects.
van Riet-Nales DA; Schobben AF; Vromans H; Egberts TC; Rademaker CM
Arch Dis Child; 2016 Jul; 101(7):662-9. PubMed ID: 26979250
[TBL] [Abstract][Full Text] [Related]
18. How can oral paediatric formulations be improved? A challenge for the XXI century.
Moreira M; Sarraguça M
Int J Pharm; 2020 Nov; 590():119905. PubMed ID: 32980507
[TBL] [Abstract][Full Text] [Related]
19. Patient Centric Pharmaceutical Drug Product Design-The Impact on Medication Adherence.
Menditto E; Orlando V; De Rosa G; Minghetti P; Musazzi UM; Cahir C; Kurczewska-Michalak M; Kardas P; Costa E; Sousa Lobo JM; Almeida IF
Pharmaceutics; 2020 Jan; 12(1):. PubMed ID: 31947888
[TBL] [Abstract][Full Text] [Related]
20. Orally Dispersible Dosage Forms for Paediatric Use: Current Knowledge and Development of Nanostructure-Based Formulations.
Cornilă A; Iurian S; Tomuță I; Porfire A
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
